Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea · Delayed Price · Currency is KRW 37,150
+250 (0.68%)
Aug 14, 2025, 2:40 PM KST
Mezzion Pharma Company Description
Mezzion Pharma Co.,Ltd. develops, manufactures, and sells pharmaceutical products in South Korea.
The company developing JURVIGO, which is in Phase 3 clinical trial for treatment option to improve the physiology and exercise capacity of Fontan patients 12 years and older.
The company was formerly known as Dong-A Pharmtech Co., Ltd. and changed its name to Mezzion Pharma Co.,Ltd. in April 2013.
Mezzion Pharma Co.,Ltd. was founded in 2002 and is headquartered in Seoul, South Korea.
Mezzion Pharma Co.,Ltd.
| Country | South Korea |
| Founded | 2002 |
| Industry | Pharmaceutical Preparations |
| Employees | 19 |
| CEO | Dong-Hyun Park |
Contact Details
Address: Seokcheon Building Seoul, 06163 South Korea | |
| Phone | 82 2 560 8000 |
| Website | mezzion.co.kr |
Stock Details
| Ticker Symbol | 140410 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7140410002 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dong-Hyun Park | Chief Executive Officer |